000 01707 a2200469 4500
005 20250516203054.0
264 0 _c20150109
008 201501s 0 0 eng d
022 _a1873-7064
024 7 _a10.1016/j.neuropharm.2014.03.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoshy Cherian, Ajeesh
245 0 0 _aA systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
_h[electronic resource]
260 _bNeuropharmacology
_cJul 2014
300 _a41-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCentral Nervous System Agents
_xpharmacology
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aGlutamic Acid
_xmetabolism
650 0 4 _aKynurenic Acid
_xmetabolism
650 0 4 _aKynurenine
_xpharmacology
650 0 4 _aMale
650 0 4 _aMembrane Potentials
_xdrug effects
650 0 4 _aMicrodialysis
650 0 4 _aMicroelectrodes
650 0 4 _aNicotine
_xpharmacology
650 0 4 _aNicotinic Agonists
_xpharmacology
650 0 4 _aPotassium Chloride
_xpharmacology
650 0 4 _aPrefrontal Cortex
_xdrug effects
650 0 4 _aPyrazoles
_xpharmacology
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRats, Wistar
650 0 4 _aTransaminases
_xantagonists & inhibitors
700 1 _aGritton, Howard
700 1 _aJohnson, David E
700 1 _aYoung, Damon
700 1 _aKozak, Rouba
700 1 _aSarter, Martin
773 0 _tNeuropharmacology
_gvol. 82
_gp. 41-8
856 4 0 _uhttps://doi.org/10.1016/j.neuropharm.2014.03.004
_zAvailable from publisher's website
999 _c23656303
_d23656303